Cyclone Pharmaceuticals (CYCN) skyrocketed 315.6% to $6.38 on exceptional 255.8 million share volume, anchoring Thursday’s market action as a speculative rally gripped micro-cap and emerging growth names. Among higher-priced equities, Elab Therapeutics gained 133.7% and Agpu Tech